Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
Net Income Growth TrendStable
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year net income growth rate

Latest
46.87%
↑ 176% vs avg
Percentile
P100
Near historical high
Streak
5 yr
Consecutive growthStable
Average
-61.71%
Historical baseline
PeriodValue
202546.87%
202446.29%
2023-24.75%
2022-46.71%
2021-106.13%
2020-347.54%
20190.00%